플라즈마 의과학센터를 방문해주신 여러분, 안녕하십니까?

플라즈마 의과학센터의 센터장
최은하입니다.

  • 현대 과학의 패러다임은 서로 다른 영역에 있던 과학이 융합 발전되어 새로운 과학이 탄생되고 발전시켜 나아가고 있습니다. 우리 연구팀은 플라즈마 과학을 바탕으로 의학, 바이오, 생명 공학 및 환경 신소재 분야와의 협력 연구를 통해 ‘플라즈마 바이오과학 및 의과학’이라는 새롭게 확장된 연구 목표를 설계하여

    미래부의 해외우수연구기관 유치사업(Global Research Development Center, GRDC)의 일환으로 독일 라이프니츠 연구소의 INP 저온 플라즈마 연구소와 공동 으로 “플라즈마 의과학 센터(Applied Plasma Medicine Center, APMC)”의 설립을 제안하였고, 유치하게 되었습니다.
  • 플라즈마 의과학 센터는 1992년 대전입자 및 플라즈마 연구실에서 시작하여 2004년 PDP 연구센터, 2010년 플라즈마 바이오과학 연구센터로 발전되어 왔고 현재에 도달하였습니다. 30여년 이상의 플라즈마에 대한 심도 깊은 연구를 기반으 로 하여, 현재는 다양한 플라즈마 바이오과학 및 의과학 관련 기초연구를 수행할 수 있는 핵심장치와 생명물질과의 상호작용을 연구할 수 있는 분석·평가 장치들을 보유하고 있습니다.

    플라즈마 의과학 센터의 연구는 바이오 플라즈마 분야의 원천핵심연구로 세계적 센터로 성장하여 의료산업의 신기술개발에 큰 가치를 창출할 것이며, 인류 복지 향상 기여할 것입니다.

    광운대학교 / 플라즈마 의과학 센터
    센터장 최은하드림

Applied Plasma Medicine Center Director
K.-D. Weltmann.

  • Ladies and Gentlemen !!
    Leibniz-Institute for Plasma Science and Technology e.V - INP Greifswald The Institute is dedicated on the one hand to establish applications such as plasma surface technology and arc technology. On the other hand, it opens and supports new fields of application, such as the use of plasma in the context of energy-efficient and resource-saving technologies, in life sciences (especially in new areas such as plasma biology, plasma medicine, plasma pharmacology) and for the degradation of pollutants. According to the motto "from idea to prototype", the basic research is closely connected with the promotion of new applications. On the one hand, innovative approaches are pursued until proof of technical feasibility. On the other hand, current problems in plasma technology serve as a point of orientation and driving force for the targeted acquisition of knowledge on the fundamentals of plasma physics.

    Structure
    The Institute in Greifswald dates back to the "Forschungsstelle für Gasentladungsphysik" (Research Centre for Gas Discharge Physics) established by Paul Schulz in 1946 and hosted by the Akademie der Wissenschaften der DDR (Academy of Sciences of the GDR). When Paul Schulz moved to Berlin in 1949, Rudolf Seeliger became director of the research centre, which in 1950 was renamed "Institut für Gasentladungsphysik" (Institute for Gas Discharge Physics) and in 1969 assigned to the "Zentralinstitut für Elektronenphysik" (ZIE) (Central Institute for Electron Physics). On 31 December 1991, the Institute was formally dissolved.

    In the design of its range of services, the INP takes into account both the requirements in research and development and the market needs in industry. The Institute has all the competencies necessary for the implementation of modern plasma applications (plasma sources particularly at atmospheric pressure and for plasma systems, plasma processes and process control technologies for surface technologies and volume processes, as well as diagnosis and modelling for the analysis of basic processes in the various forms of discharge). These competencies are reflected in the scientific organizational units (Scientific Departments) and are incorporated into the current topics of the Research Divisions.
  • The main task of the INP Research Program Plasma Medicine is to realize basic research and application oriented research in the field of biomedical application of cold atmospheric plasma and to support and organize the transfer of research results both to clinical research and to industrial application. During the last years this research was generously fostered by research grants from the Federal Ministry of Education and Research as well as the Ministry of Education, Science and Culture of Mecklenburg-Western Pomerania. With this work, INP Greifswald was able to establish itself to one of the world’s leading centers of the innovative research field plasma medicine. This was acknowledged by the evaluation of the Leibniz Association in 2014, where the research program was ranked as “excellent”. This was among other things motivated by the fact that research outcomes of this research program “set international standards in this young research field”.

    Not least thanks to the systematic basic research mainly realized by the INP-adjunct Centre for Innovation Competence (ZIK) “plasmatis - Plasma plus cell” two fundamental insights on main mechanisms of plasma-cell and plasma-tissue interactions are identified:
    · Biological plasma effects are significantly caused by plasma induced changes of the liquid environment of cells, and
    · Biological plasma effects are dominated by reactive oxygen and nitrogen species generated in or transferred into liquid phases by plasma treatment.

    The highlight of application-oriented research in plasma medicine was the CE certification of the cold atmospheric plasma jet kinpen Med by neoplas tools GmbH in 2013, which was mainly based on INP research effort. Starting with the availability of this certified medical device, clinical plasma application has been growing at first for treatment of chronic wounds as well as pathogen-based diseases of skin. Based on this and in cooperation with neoplas tools GmbH, several research partnerships with clinics could be opened or consolidated in 2014 and 2015, among others with different clinics in Germany.

    Director, APMC
    K.-D. Weltmann